Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma
Forimtamig 是一种新型的靶向 GPRC5D 的 T 细胞双特异性抗体，采用 2+1 结构，用于治疗多发性骨髓瘤。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024025987
Eckmann, Jan; Fauti, Tanja; Biehl, Marlene; Zabaleta, Aintzane; Blanco, Laura; Lelios, Iva; Gottwald, Stefan; Rae, Richard; Lechner, Stefanie; Bayer, Christa; Dekempe, Quincy; Osl, Franz; Carrié, Nadege; Kassem, Sahar; Lorenz, Stefan; Christopeit, Tony; Carpy, Alejandro; Bujotzek, Alexander; Bröske, Ann-Marie; Dekhtiarenko, Iryna; Attig, Jan; Kunz, Leo; Cremasco, Floriana; Adelfio, Roberto; Fertig, Georg; Dengl, Stefan; Gassner, Christian; Bormann, Felix; Kirstenpfad, Claudia; Kraft, Thomas; Diggelmann, Sarah; Knobloch, Melanie; Hage, Carina; Feddersen, Romi; Heidkamp, Gordon; Pöschinger, Thomas; Mayoux, Maud; Bernasconi, Luise; Prosper, Felipe; Dumontet, Charles; Martinet, Ludovic; Leclair, Stéphane; Xu, Wei; Paiva, Bruno; Klein, Christian; Umaña, Pablo
